Detalhe da pesquisa
1.
Phase I/II clinical trial of temsirolimus and lenalidomide in patients with relapsed and refractory lymphomas.
Haematologica
; 107(7): 1608-1618, 2022 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34320785
2.
Venetoclax plus R- or G-CHOP in non-Hodgkin lymphoma: results from the CAVALLI phase 1b trial.
Blood
; 133(18): 1964-1976, 2019 05 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30850381
3.
Impact of treatment variability on survival in immuno-competent and immuno-compromised patients with primary central nervous lymphoma.
Br J Haematol
; 177(1): 72-79, 2017 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-28211579
4.
Frequency, risk factors, and outcomes of central nervous system relapse in lymphoma patients treated with dose-adjusted EPOCH plus rituximab.
Am J Hematol
; 92(11): 1156-1162, 2017 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-28719025
5.
Impact of oncogene rearrangement patterns on outcomes in patients with double-hit non-Hodgkin lymphoma.
Cancer
; 122(4): 559-64, 2016 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-26565895
6.
Sole rearrangement but not amplification of MYC is associated with a poor prognosis in patients with diffuse large B cell lymphoma and B cell lymphoma unclassifiable.
Br J Haematol
; 175(4): 631-640, 2016 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-27469075
7.
Impact of induction regimen and stem cell transplantation on outcomes in double-hit lymphoma: a multicenter retrospective analysis.
Blood
; 124(15): 2354-61, 2014 Oct 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-25161267
8.
Factors predicting survival in peripheral T-cell lymphoma in the USA: a population-based analysis of 8802 patients in the modern era.
Br J Haematol
; 168(5): 708-18, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25382108
9.
Gray zone lymphoma with features intermediate between classical Hodgkin lymphoma and diffuse large B-cell lymphoma: characteristics, outcomes, and prognostication among a large multicenter cohort.
Am J Hematol
; 90(9): 778-83, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-26044261
10.
MYC-associated and double-hit lymphomas: a review of pathobiology, prognosis, and therapeutic approaches.
Cancer
; 120(24): 3884-95, 2014 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-25060588
11.
F-18 FDG-PET predicts outcomes for patients receiving total lymphoid irradiation and autologous blood stem-cell transplantation for relapsed and refractory Hodgkin lymphoma.
Br J Haematol
; 165(6): 793-800, 2014 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-24628515
12.
Multiple successful desensitizations to brentuximab vedotin: a case report and literature review.
J Natl Compr Canc Netw
; 12(4): 465-71, 2014 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-24717566
13.
Peripheral T-cell lymphoma: new therapeutic strategies.
Oncology (Williston Park)
; 27(9): 878-84, 2013 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-24282984
14.
Ibrutinib, a Bruton's tyrosine kinase inhibitor used for treatment of lymphoproliferative disorders, eliminates both aeroallergen skin test and basophil activation test reactivity.
J Allergy Clin Immunol
; 140(3): 875-879.e1, 2017 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-28389390
15.
Multicenter phase 2 study of romidepsin plus lenalidomide for previously untreated peripheral T-cell lymphoma.
Blood Adv
; 7(19): 5771-5779, 2023 10 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37327113
16.
Ibrutinib maintenance after frontline treatment in patients with mantle cell lymphoma.
Blood Adv
; 7(23): 7361-7368, 2023 12 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37756532
17.
Emerging Therapeutic Targets in Diffuse Large B-Cell Lymphoma.
Curr Treat Options Oncol
; 13(1): 82-101, 2012 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-22297843
18.
Pancreatitis in patients treated with brentuximab vedotin: a previously unrecognized serious adverse event.
Blood
; 123(18): 2895-7, 2014 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-24786458
19.
A phase I/II trial of brentuximab vedotin plus rituximab as frontline therapy for patients with immunosuppression-associated CD30+ and/or EBV + lymphomas.
Leuk Lymphoma
; 62(14): 3493-3500, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34338127
20.
Outcomes of Patients With Double-Hit Lymphoma Who Achieve First Complete Remission.
J Clin Oncol
; 35(20): 2260-2267, 2017 Jul 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-28475457